Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi

Clinical and Vaccine Immunology

Volumn 14, Issue 7, 2007, Pages 875-879

  Gomes Solecki, Maria J C ^a,c   Meirelles, Luciana ^a   Glass, John ^b   Dattwyler, Raymond J ^a,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c Biopeptides Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; EPITOPE; MEMBRANE ANTIGEN; PEPTIDES AND PROTEINS; PROTEIN IR6; UNCLASSIFIED DRUG; VARIABLE SURFACE ANTIGEN;

ANTIBODY DETECTION; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MAPPING; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; AMINO ACID SEQUENCE; BLOOD; CLASSIFICATION; EPITOPE MAPPING; EUROPE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; UNITED STATES;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; EUROPE; HUMANS; LYME DISEASE; MOLECULAR SEQUENCE DATA; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; UNITED STATES;

EID: 35748976833     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00122-07     Document Type: Article

References (18)

1. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, Jr., M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199.
2. Belman, A. L., M. Iyer, P. K. Coyle, and R. Dattwyler. 1993. Neurologic manifestations in children with North American Lyme disease. Neurology 43:2609-2614.
3. Cinco, M., and R. Murgia. 2006. Evaluation of the C6 enzyme-linked immunoadsorbent assay for the serodiagnosis of Lyme borreliosis in northeastern Italy. New Microbiol. 29:139-141.
4. Jansson, C., S. A. Carlsson, H. Granlund, P. Wahlberg, and D. Nyman. 2005. Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA. Clin. Microbiol. Infect. 11:147-150.
5. Liang, F. T., A. L. Alvarez, Y. Gu, J. M. Nowling, R. Ramamoorthy, and M. T. Philipp. 1999. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J. Immunol. 163:5566-5573.
6. Liang, F. T., and M. T. Philipp. 1999. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect. Immun. 67:6702-6706.
7. Liang, F. T., and M. T. Philipp. 2000. Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species. Infect. Immun. 68:2349-2352.
8. Liang, F. T., A. C. Steere, A. R. Marques, B. J. B. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
9. Marangoni, A., M. Sparacino, F. Cavrini, E. Storni, V. Mondardini, V. Sambri, and R. Cevenini. 2005. Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J. Med. Microbiol. 54:361-367.
10. Marangoni, A., M. Sparacino, V. Mondardini, F. Cavrini, E. Storni, M. Donati, R. Cevenini, and V. Sambri. 2005. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. New Microbiol. 28:37-43.
11. Mogilyansky, E., C. C. Loa, M. E. Adelson, E. Mordechai, and R. C. Tilton. 2004. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin. Diagn. Lab. Immunol. 11:924-929.
12. Nyman, D., L. Willen, C. Jansson, S. A. Carlsson, H. Granlund, and P. Wahlberg. 2006. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area. Clin. Microbiol. Infect. 12:496-497.
13. Peltomaa, M., G. McHugh, and A. C. Steere. 2004. The VlsE (IR6) peptide ELISA in the serodiagnosis of Lyme facial paralysis. Otol. Neurotol. 25:838-841.
14. 6 Lyme test. Clin. Vaccine Immunol. 13:1170-1171.
15. Sillanpaa, H., P. Lahdenne, H. Sarvas, M. Arnez, A. Steere, M. Peltomaa, and I. Seppala. 2007. Immune responses to borrelial VlsE IR6 peptide variants. Int. J. Med. Microbiol. 297:45-52.
16. Smismans, A., V. J. Goossens, E. Nulens, and C. A. Bruggeman. 2006. Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. Clin. Microbiol. Infect. 12:648-655.
17. Tjernberg, I., G. Kruger, and I. Eliasson. 2007. C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden. Eur. J. Clin. Microbiol. Infect. Dis. 26:37-42.
18. Wormser, G. P., R. J. Dattwyler, E. D. Shapiro, J. J. Halperin, A. C. Steere, M. S. Klempner, P. J. Krause, J. S. Bakken, F. Strle, G. Stanek, L. Bockenstedt, D. Fish, J. S. Dumler, and R. B. Nadelman. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43:1089-1134.